Bacteriophage therapy plus fecal microbiota transplantation to treat recurrent urinary tract infection (rUTI): a case series
Abstract
Abstract Recurrent urinary tract infections (rUTIs) are a chronic, debilitating condition characterized by repeated infections and treatment failure with antibiotics. We present an attempt to decolonize the urinary and intestinal reservoirs between acute UTI episodes in three female patients suffering from rUTI caused by Escherichia coli using a combined approach of semi-personalized phage therapy followed by fecal microbiota transplantation (FMT). Patients with long-term urinary detection of phage-susceptible E. coli received eight days of oral and intravesical phage application followed by antibiotics prior to FMT. Pathogen titers decreased significantly after local administration, and phage concentrations were maintained in the urine between doses after several days. While E. coli was detected in follow-up samples, patients experienced less frequent and less severe episodes of acute UTI 24 months post-treatment. Genetic analysis of pre- and post-treatment strains revealed a strain replacement for one patient. Metagenomic shotgun sequencing of stool samples confirmed engraftment in FMT recipients.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.